2022
DOI: 10.1371/journal.pone.0274424
|View full text |Cite
|
Sign up to set email alerts
|

One-session treatment for specific phobias: Barriers, facilitators and acceptability as perceived by children & young people, parents, and clinicians

Abstract: Between 2015 and 2020 the Alleviating Specific Phobias Experienced by Children Trial (ASPECT) was conducted in the UK to examine the non-inferiority of One-Session Treatment in comparison to Cognitive Behavioural Therapy based interventions for children and young people with specific phobias. A nested qualitative evaluation was conducted as part of this trial to examine the acceptability of One-Session Treatment. Qualitative interviews were conducted with children and young people taking part in the trial, the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…ASPECT was a pragmatic, multi‐center, parallel group non‐inferiority RCT, comparing the clinical and cost‐effectiveness of OST with multi‐session CBT. A nested qualitative study exploring the acceptability of OST to CYP, their parent/guardians, and therapists and a full economic evaluation are reported elsewhere (Hayward et al., 2022 ; Wang et al., 2022 ).…”
Section: Methodsmentioning
confidence: 99%
“…ASPECT was a pragmatic, multi‐center, parallel group non‐inferiority RCT, comparing the clinical and cost‐effectiveness of OST with multi‐session CBT. A nested qualitative study exploring the acceptability of OST to CYP, their parent/guardians, and therapists and a full economic evaluation are reported elsewhere (Hayward et al., 2022 ; Wang et al., 2022 ).…”
Section: Methodsmentioning
confidence: 99%
“…Adapted with permission from Hayward et al42 © 2022 Hayward et al This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.…”
mentioning
confidence: 99%